{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:32:11Z","timestamp":1793604731774,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T00:00:00Z","timestamp":1524182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41380-018-0047-z","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T11:05:23Z","timestamp":1524222323000},"page":"1478-1488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":174,"title":["Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents"],"prefix":"10.1038","volume":"24","author":[{"given":"Xinyu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghui","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun V","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Coghill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lining","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E","family":"Hetrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Benoliel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5179-8321","authenticated-orcid":false,"given":"Andrea","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,20]]},"reference":[{"key":"47_CR1","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1469-7610.2006.01682.x","volume":"47","author":"E Jane Costello","year":"2006","unstructured":"Jane Costello E, Erkanli A, Angold A. Is there an epidemic of child or adolescent depression? J Child Psychol Psychiatry. 2006;47:1263\u201371.","journal-title":"J Child Psychol Psychiatry"},{"key":"47_CR2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2005;62:593\u2013602.","journal-title":"Arch Gen Psychiatry"},{"key":"47_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1136\/bmj.325.7358.229","volume":"325","author":"H Philip","year":"2002","unstructured":"Philip H. Depression in children may go unnoticed and untreated. Br Med J. 2002;325:229\u201330.","journal-title":"Br Med J"},{"key":"47_CR4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1037\/a0034733","volume":"140","author":"CM Cummings","year":"2014","unstructured":"Cummings CM, Caporino NE, Kendall PC. Comorbidity of anxiety and depression in children and adolescents: 20 years after. Psychol Bull. 2014;140:816\u201345.","journal-title":"Psychol Bull"},{"key":"47_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-0739-3","volume":"16","author":"AJ Lundervold","year":"2016","unstructured":"Lundervold AJ, Hinshaw SP, S\u00f8rensen L, Posserud MB. Co-occurring symptoms of attention deficit hyperactivity disorder (ADHD) in a population-based sample of adolescents screened for depression. BMC Psychiatry. 2016;16:46.","journal-title":"BMC Psychiatry"},{"key":"47_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/eb-2017-102667","volume":"20","author":"G Cox","year":"2017","unstructured":"Cox G,\u00a0Hetrick S. Psychosocial\u00a0interventions\u00a0for\u00a0self harm, suicidal ideation and\u00a0 suicide attempt\u00a0in\u00a0children\u00a0and\u00a0young\u00a0people: What? How?\u00a0Who? and\u00a0Where? Evid Based Ment Health. 2017;20:35-40.","journal-title":"Evid Based Ment Health"},{"key":"47_CR7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(16)30385-3","volume":"388","author":"A Cipriani","year":"2016","unstructured":"Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet. 2016;388:881\u201390.","journal-title":"Lancet"},{"issue":"10128","key":"47_CR8","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"Andrea Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressants drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018 Feb 20. pii: S0140-6736(17)32802-7. https:\/\/doi.org\/10.1016\/S0140-6736(17)32802-7 . [Epub ahead of print]","journal-title":"The Lancet"},{"key":"47_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/pcn.12372","volume":"70","author":"N Mao","year":"2016","unstructured":"Mao N, Fang J, Xie H, Liu X, Jiang X, Wang G, et al. Correlation between neurochemical metabolism and memory function in adolescent patients with depression: A multi-voxel (1) H magnetic resonance spectroscopy study. Psychiatry Clin Neurosci. 2016;70:167\u201374.","journal-title":"Psychiatry Clin Neurosci"},{"key":"47_CR10","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1176\/appi.ajp.2007.06122032","volume":"164","author":"V Gabbay","year":"2007","unstructured":"Gabbay V, Hess DA, Liu S, Babb JS, Klein RG, Gonen O. Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study. Am J Psychiatry. 2007;164:1881\u20139.","journal-title":"Am J Psychiatry"},{"key":"47_CR11","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0006-3223(00)00942-2","volume":"48","author":"RJ Steingard","year":"2000","unstructured":"Steingard RJ, Yurgelun-Todd DA, Hennen J, Moore JC, Moore CM, Vakili K, et al. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry. 2000;48:1053\u201361.","journal-title":"Biol Psychiatry"},{"key":"47_CR12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.neuint.2007.06.025","volume":"51","author":"DB Bylund","year":"2007","unstructured":"Bylund DB, Reed AL. Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs? Neurochem Int. 2007;51:246\u201353.","journal-title":"Neurochem Int"},{"key":"47_CR13","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.adolescence.2014.05.012","volume":"37","author":"CL Rocque La","year":"2014","unstructured":"La Rocque CL, Harkness KL, Bagby RM. The differential relation of childhood maltreatment to stress sensitization in adolescent and young adult depression. J Adolesc. 2014;37:871\u201382.","journal-title":"J Adolesc"},{"key":"47_CR14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.bcp.2007.01.028","volume":"73","author":"LC Murrin","year":"2007","unstructured":"Murrin LC, Bylund DB. Comparison of the Maturation of the Adrenergic and Serotonergic Neurotransmitter Systems in the Brain: Potential Insights into Childhood and Adolescent Depression. Biochem Pharmacol. 2007;73:1225\u201336.","journal-title":"Biochem Pharmacol"},{"key":"47_CR15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/archpsyc.57.9.867","volume":"57","author":"B Birmaher","year":"2000","unstructured":"Birmaher B, Dahl RE, Williamson DE, Perel JM, Brent DA, Axelson DA, et al. Growth hormone secretion in children and adolescents at high risk for major depressive disorder. Arch Gen Psychiatry. 2000;57:867\u201372.","journal-title":"Arch Gen Psychiatry"},{"key":"47_CR16","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1021\/pr2010082","volume":"11","author":"P Zheng","year":"2012","unstructured":"Zheng P, Gao HC, Li Q, Shao WH, Zhang ML, Cheng K, et al. Plasma metabonomics as a novel diagnostic approach for major depressive disorder. J Proteome Res. 2012;11:1741\u20138.","journal-title":"J Proteome Res"},{"key":"47_CR17","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1021\/acs.jproteome.5b00144","volume":"14","author":"X Liu","year":"2015","unstructured":"Liu X, Zheng P, Zhao X, Zhang Y, Hu C, Li J, et al. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry. J Proteome Res. 2015;14:2322\u201330.","journal-title":"J Proteome Res"},{"key":"47_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1074\/mcp.M112.021816","volume":"12","author":"P Zheng","year":"2013","unstructured":"Zheng P, Wang Y, Chen L, Yang D, Meng H, Zhou D, et al. Identification and validation of urinary metabolite biomarkers for major depressive disorder. Mol Cell Proteom. 2013;12:207\u201314.","journal-title":"Mol Cell Proteom"},{"key":"47_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jad.2016.02.008","volume":"195","author":"P Zheng","year":"2016","unstructured":"Zheng P, Fang Z, Xu XJ, Liu ML, Du X, Zhang X, et al. Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells. J Affect Disord. 2016;195:75\u201381.","journal-title":"J Affect Disord"},{"key":"47_CR20","unstructured":"Poznanski EO, Mokros HB. Children\u2019s depression rating scale, revised (CDRS-R): manual. Los Angeles: Western Psychological Services, 1996."},{"key":"47_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"47_CR22","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/mp.2015.217","volume":"21","author":"N Yoshimi","year":"2016","unstructured":"Yoshimi N, Futamura T, Bergen SE, Iwayama Y, Ishima T, Sellgren C, et al. Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis. Mol Psychiatry. 2016;21:1504\u201310.","journal-title":"Mol Psychiatry"},{"key":"47_CR23","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1039\/c3mb70614a","volume":"10","author":"XJ Xu","year":"2014","unstructured":"Xu XJ, Zheng P, Ren GP, Liu ML, Mu J, Guo J, et al. 2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder. Mol Biosyst. 2014;10:813\u20139.","journal-title":"Mol Biosyst"},{"key":"47_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jnim.2016.04.004","volume":"5","author":"RK McNamara","year":"2016","unstructured":"McNamara RK. Role of omega-3 fatty acids in the etiology, treatment, and prevention of depression: current status and future directions. J Nutr Intermed Metab. 2016;5:96\u2013106.","journal-title":"J Nutr Intermed Metab"},{"key":"47_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.psychres.2014.11.018","volume":"225","author":"S Tsuchimine","year":"2015","unstructured":"Tsuchimine S, Saito M, Kaneko S, Yasui-Furukori N. Decreased serum levels of polyunsaturated fatty acids and folate, but not brain-derived neurotrophic factor, in childhood and adolescent females with depression. Psychiatry Res. 2015;225:187\u201390.","journal-title":"Psychiatry Res"},{"key":"47_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.biochi.2007.01.009","volume":"89","author":"Y Mizushina","year":"2007","unstructured":"Mizushina Y, Dairaku I, Yanaka N, Takeuchi T, Ishimaru C, Sugawara F, et al. Inhibitory action of polyunsaturated fatty acids on IMP dehydrogenase. Biochimie. 2007;89:581\u201390.","journal-title":"Biochimie"},{"key":"47_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1042\/bj3150329","volume":"315","author":"D Martin","year":"1996","unstructured":"Martin D, Meckling-Gill KA. Omega-3 polyunsaturated\u2002fatty acids\u2002increase\u2002purine\u2002but not pyrimidine transport in L1210 leukaemia cells. Biochem J. 1996;315:329\u201333. Pt 1","journal-title":"Biochem J"},{"key":"47_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/YCO.0b013e3282f29841","volume":"21","author":"C Owen","year":"2008","unstructured":"Owen C, Rees AM, Parker G. The role of fatty acids in the development and treatment of mood disorders. Curr Opin Psychiatry. 2008;21:19\u201324.","journal-title":"Curr Opin Psychiatry"},{"key":"47_CR29","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1176\/ajp.2006.163.6.1098","volume":"163","author":"H Nemets","year":"2006","unstructured":"Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry. 2006;163:1098\u2013100.","journal-title":"Am J Psychiatry"},{"key":"47_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1176\/appi.ajp.159.3.477","volume":"159","author":"B Nemets","year":"2002","unstructured":"Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002;159:477\u20139.","journal-title":"Am J Psychiatry"},{"key":"47_CR31","first-page":"38","volume":"2","author":"RK McNamara","year":"2014","unstructured":"McNamara RK, Strimpfel J, Jandacek R, Rider T, Tso P, Welge JA, et al. Detection and treatment of long-chain omega-3 fatty acid deficiency in adolescents with SSRI-resistant major depressive disorder. Pharm Nutr. 2014;2:38\u201346.","journal-title":"Pharm Nutr."},{"key":"47_CR32","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jad.2014.12.031","volume":"174","author":"R Tao","year":"2015","unstructured":"Tao R, Li H. High serum uric acid level in adolescent depressive patients. J Affect Disord. 2015;174:464\u20136.","journal-title":"J Affect Disord"},{"key":"47_CR33","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.2174\/138161205774913255","volume":"11","author":"GK Glantzounis","year":"2005","unstructured":"Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des. 2005;11:4145\u201351.","journal-title":"Curr Pharm Des"},{"key":"47_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.arcmed.2006.10.005","volume":"38","author":"H Herken","year":"2007","unstructured":"Herken H, Gurel A, Selek S, Armutcu F, Ozen ME, Bulut M, et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res. 2007;38:247\u201352.","journal-title":"Arch Med Res"},{"key":"47_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.psyneuen.2016.04.017","volume":"70","author":"T Ali-Sisto","year":"2016","unstructured":"Ali-Sisto T, Tolmunen T, Toffol E, Viinam\u00e4ki H, M\u00e4ntyselk\u00e4 P, Valkonen-Korhonen M, et al. Purine metabolism is dysregulated in patients with major depressive disorder. Psychoneuroendocrinology. 2016;70:25\u201332.","journal-title":"Psychoneuroendocrinology"},{"key":"47_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12987-015-0017-7","volume":"12","author":"MS Bynoe","year":"2015","unstructured":"Bynoe MS, Viret C, Yan A, Kim DG. Adenosine receptor signaling: a key to opening the blood-brain door. Fluids Barriers CNS. 2015;12:20.","journal-title":"Fluids Barriers CNS"},{"key":"47_CR37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/978-3-540-89615-9_16","volume":"193","author":"AM Sebasti\u00e3o","year":"2009","unstructured":"Sebasti\u00e3o AM, Ribeiro JA. Adenosine receptors and the central nervous system. Handb Exp Pharmacol. 2009;193:471\u2013534.","journal-title":"Handb Exp Pharmacol"},{"key":"47_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11302-012-9299-2","volume":"8","author":"F Rocha Lapa da","year":"2012","unstructured":"da Rocha Lapa F, da Silva MD, de Almeida Cabrini D, Santos AR. Anti-inflammatory effects of purine nucleosides, adenosine and inosine, in a mouse model of pleurisy: evidence for the role of adenosine A2 receptors. Purinergic Signal. 2012;8:693\u2013704.","journal-title":"Purinergic Signal"},{"key":"47_CR39","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jad.2011.07.010","volume":"135","author":"DG Kondo","year":"2011","unstructured":"Kondo DG, Sung YH, Hellem TL, Fiedler KK, Shi X, Jeong EK, et al. Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study. J Affect Disord. 2011;135:354\u201361.","journal-title":"J Affect Disord"},{"key":"47_CR40","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s11302-013-9361-8","volume":"9","author":"MP Kaster","year":"2013","unstructured":"Kaster MP, Budni J, Gazal M, Cunha MP, Santos AR, Rodrigues AL. The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A 2A receptors. Purinergic Signal. 2013;9:481\u20136.","journal-title":"Purinergic Signal"},{"key":"47_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11302-016-9551-2","volume":"13","author":"FM Gon\u00e7alves","year":"2017","unstructured":"Gon\u00e7alves FM, Neis VB, Rieger DK, Lopes MW, Heinrich IA, Costa AP, et al. Signaling pathways underlying the antidepressant-like effect of inosine in mice. Purinergic Signal. 2017;13:203\u201314.","journal-title":"Purinergic Signal"},{"key":"47_CR42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.18388\/abp.1997_4372","volume":"44","author":"K Yagi","year":"1997","unstructured":"Yagi K. Female hormones act as natural antioxidants\u2013a survey of our research. Acta Biochim Pol. 1997;44:701\u20139.","journal-title":"Acta Biochim Pol"},{"key":"47_CR43","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S0006-3223(01)01127-1","volume":"49","author":"J Kaufman","year":"2001","unstructured":"Kaufman J, Martin A, King RA, Charney D. Are child-, adolescent-, and adult-onset depression one and the same disorder? Biol Psychiatry. 2001;49:980\u20131001.","journal-title":"Biol Psychiatry"},{"key":"47_CR44","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1097\/00004583-199407000-00006","volume":"33","author":"PM Lewinsohn","year":"1994","unstructured":"Lewinsohn PM, Clarke GN, Seeley JR, Rhode P. Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry. 1994;33:809\u201318.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"47_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/0269881115609072","volume":"30","author":"S K\u00f6hler","year":"2016","unstructured":"K\u00f6hler S, Cierpinsky K, Kronenberg G, Adli M. The serotonergic system in the neurobiology of depression: relevance for novel antidepressants. J Psychopharmacol. 2016;30:13\u201322.","journal-title":"J Psychopharmacol"},{"key":"47_CR46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1600-079X.2009.00741.x","volume":"48","author":"S Esteban","year":"2010","unstructured":"Esteban S, Garau C, Aparicio S, Moranta D, Barcel\u00f3 P, Fiol MA, et al. Chronic melatonin treatment and its precursor L-tryptophan improve the monoaminergic neurotransmission and related behavior in the aged rat brain. J Pineal Res. 2010;48:170\u20137.","journal-title":"J Pineal Res"},{"key":"47_CR47","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3945\/ajcn.110.000950","volume":"93","author":"A O\u2019Sullivan","year":"2011","unstructured":"O\u2019Sullivan A, Gibney MJ, Brennan L. Dietary intake patterns are reflected in metabolomic profiles: potential role in dietary assessment studies. Am J Clin Nutr. 2011;93:314\u201321.","journal-title":"Am J Clin Nutr"},{"key":"47_CR48","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1017\/S0029665112000699","volume":"71","author":"C Morris","year":"2012","unstructured":"Morris C, O\u2019Grada C, Ryan M, Roche HM, Gibney MJ, Gibney ER, et al. The relationship between BMI and metabolomic profiles: a focus on amino acids. Proc Nutr Soc. 2012;71:634\u20138.","journal-title":"Proc Nutr Soc"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0047-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0047-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0047-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T05:21:45Z","timestamp":1720243305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-018-0047-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,20]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1038\/s41380-018-0047-z","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,20]]},"assertion":[{"value":"13 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}